Company page
China Regenerative Medicine International Limited
China Regenerative Medicine International Limited, trading under the ticker 8158 on the Hong Kong Stock Exchange, focuses on the development and commercialization of regenerative medicine products. The company has a market capitalization of approximately HKD 12.42 million. Its initiatives aim to advance healthcare solutions through innovative therapies and technologies in the regenerative medicine sector.
- Ticker
- 8158:HKEX
- Asset type
- Stock
- Market cap
- $12.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD